Contact
Please use this form to send email to PR contact of this press release:
Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases
TO:
Keith Pinder
Landon Capital
+1 404-995-6671